Cargando…

Base editing: a novel cure for severe combined immunodeficiency

Detalles Bibliográficos
Autores principales:	Ha, Teng-Cheong, Morgan, Michael, Schambach, Axel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505606/ https://www.ncbi.nlm.nih.gov/pubmed/37718346 http://dx.doi.org/10.1038/s41392-023-01586-2

Ejemplares similares

Prime time for base editing in the mitochondria
por: Morgan, Michael A., et al.
Publicado: (2022)

Skeletal muscle-directed gene therapy: hijacking the fusogenic properties of muscle cells
por: Büning, Hildegard, et al.
Publicado: (2023)

Targeted cytokine delivery: cell therapy to remodel the pre-metastatic niche
por: Morgan, Michael A., et al.
Publicado: (2021)

Editing base in mouse model
por: Wang, Haoyi
Publicado: (2017)

Adenine base editing to mimic or correct disease mutations in rodents
por: Ren, Ruotong, et al.
Publicado: (2018)

Genome editing enables defense-yield balance in rice
por: Deng, Yiwen, et al.
Publicado: (2023)

Back to pluripotency: fully chemically induced reboot of human somatic cells
por: Lange, Lucas, et al.
Publicado: (2022)

Skeletal Editing—Nitrogen Deletion of Secondary Amines by Anomeric Amide Reagents
por: Zippel, Christoph, et al.
Publicado: (2021)

Base editing: a promising tool to rescue spinal muscular atrophy
por: Bhatia, Priyanka, et al.
Publicado: (2023)

Editing cholesterol out of the blood
por: Abbott, Ben
Publicado: (2021)

CRISPR-mediated RNA base editing: a promising strategy to rescue deafness
por: Liu, Wenyi, et al.
Publicado: (2023)

Promoting RNA editing by ADAR attraction
por: Danan-Gotthold, Miri, et al.
Publicado: (2017)

High-throughput base editing: a promising technology for precision medicine and drug discovery
por: Sachinidis, Agapios
Publicado: (2021)

Membrane-destabilizing ionizable phospholipids: Novel components for organ-selective mRNA delivery and CRISPR–Cas gene editing
por: Meng, Ning, et al.
Publicado: (2021)

CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool
por: Xu, MengMeng
Publicado: (2020)

CRISPR-mediated genome editing of Plasmodium falciparum malaria parasites
por: Lee, Marcus CS, et al.
Publicado: (2014)

DNA-guided genome editing using structure-guided endonucleases
por: Varshney, Gaurav K., et al.
Publicado: (2016)

Enhancing prime editing via inhibition of mismatch repair pathway
por: Jiang, Lurong, et al.
Publicado: (2022)

On demand CRISPR-mediated RNA N6-methyladenosine editing
por: Xu, Ying, et al.
Publicado: (2022)

Pralidoxime and pesticide poisoning: A question of severity?
por: Walton, Emma Louise
Publicado: (2016)

Identification of evolutionarily meaningful information within the mammalian RNA editing landscape
por: Savva, Yiannis A, et al.
Publicado: (2014)

Eliminate mitochondrial diseases by gene editing in germ-line cells and embryos
por: Wang, Si, et al.
Publicado: (2015)

The Cpf1 CRISPR-Cas protein expands genome-editing tools
por: Fagerlund, Robert D., et al.
Publicado: (2015)

Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

Engineered virus-like particles: paving the way for effective somatic genome editing
por: Zhuo, Chenya, et al.
Publicado: (2022)

New case of HIV cure: joined forces of haploidentical stem cells and HLA-mismatched cord blood
por: Peterhoff, David
Publicado: (2023)

Pac-Man like DNA cut-and-paste tool allows larger gene edits
por: Akhtar, Anam
Publicado: (2020)

DSSylation, a novel guide for protein degradation?
por: Gong, Cheng-Xin
Publicado: (2014)

Antibiotics for mastitis in breastfeeding women
por: Jahanfar, Shayesteh, et al.
Publicado: (2015)

Restoring expression of Stathmin-2: a novel strategy to treat TDP-43 proteinopathies
por: Menge, Sonja, et al.
Publicado: (2023)

Mining for novel antibiotics in the age of antimicrobial resistance
por: Udaondo, Zulema, et al.
Publicado: (2020)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Potential mechanisms by which impaired ketogenesis links metabolism to T‐cell dysfunction in patients with severe COVID‐19
por: Wang, Bin, et al.
Publicado: (2022)

Dual functions of a novel effector in the plant and pathogen arms race
por: Lu, Han, et al.
Publicado: (2023)

A novel pig model capturing clinical symptoms of harlequin ichthyosis
por: Lee, Kiho
Publicado: (2019)

Deletion of the RNA-editing enzyme ADAR1A: new strategy to potentiate responses to PD-1 immune checkpoint blockade
por: Wang, Manni, et al.
Publicado: (2019)

Struggling to get a universal meningococcal vaccine and novel uses for bacterial toxins in cancer treatment
por: Daniels, Craig, et al.
Publicado: (2010)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Kidney injury molecule-1: a novel entry factor for SARS-CoV-2
por: Wan, Cheng, et al.
Publicado: (2021)

A novel “complement–metabolism–inflammasome axis” as a key regulator of immune cell effector function
por: Arbore, Giuseppina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m8hfsbfvucg0ki4bcvits4plkj